Literature DB >> 12375688

Update: Investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion--Michigan, 2002.

.   

Abstract

On September 27, 2002, this report was posted on the MMWR website (http://www.cdc.gov/mmwr). CDC, the Food and Drug Administration (FDA), the Health Resources and Services Administration (HRSA), and state and local health departments continue to investigate West Nile virus (WNV) infections in recipients of organ transplantation and blood transfusion. This report summarizes two investigations of Michigan recipients of blood products, one of whom also received a liver transplant. Both persons tested positive for WNV infection after receiving blood products derived from a single blood donation subsequently found to have evidence of WNV. These investigations provide further evidence that WNV is transmitted through blood transfusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12375688

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  16 in total

Review 1.  West Nile virus.

Authors:  Bob Nosal; Rosanan Pellizzari
Journal:  CMAJ       Date:  2003-05-27       Impact factor: 8.262

2.  Structure and function of the 3' terminal six nucleotides of the west nile virus genome in viral replication.

Authors:  Mark Tilgner; Pei-Yong Shi
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

3.  West Nile virus in Italy: a further threat to blood safety, a further challenge to the blood system.

Authors:  Giuliano Grazzini; Giancarlo Maria Liumbruno; Simonetta Pupella; Anna Rita Silvestri; Vanda Randi; Nadia Pascarelli; Paolo Zucchelli; Antonino Di Caro; Nadir Spataro; Erika D'Angelo; Vittorio Sambri
Journal:  Blood Transfus       Date:  2008-10       Impact factor: 3.443

Review 4.  Risk factors for West Nile virus infection and disease in populations and individuals.

Authors:  Ruth R Montgomery; Kristy O Murray
Journal:  Expert Rev Anti Infect Ther       Date:  2015-01-30       Impact factor: 5.091

5.  West nile virus infection in the United States: overview as a public health issue.

Authors:  Joseph R Dalovisio
Journal:  Ochsner J       Date:  2003

6.  Evaluation of a diagnostic algorithm using immunoglobulin M enzyme-linked immunosorbent assay to differentiate human West Nile Virus and St. Louis Encephalitis virus infections during the 2002 West Nile Virus epidemic in the United States.

Authors:  Denise A Martin; Amanda Noga; Olga Kosoy; Alison J Johnson; Lyle R Petersen; Robert S Lanciotti
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

Review 7.  Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features.

Authors:  Drew J Winston; Holenarasipur R Vikram; Ingrid B Rabe; Gundeep Dhillon; David Mulligan; Johnny C Hong; Ronald W Busuttil; Marek J Nowicki; Thomas Mone; Rachel Civen; Selam A Tecle; Kavita K Trivedi; Susan N Hocevar
Journal:  Transplantation       Date:  2014-05-15       Impact factor: 4.939

8.  Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination.

Authors:  Susan J Wong; Rebekah H Boyle; Valerie L Demarest; Anh N Woodmansee; Laura D Kramer; Hongmin Li; Michael Drebot; Raymond A Koski; Erol Fikrig; Denise A Martin; Pei-Yong Shi
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

9.  West Nile virus meningitis in a chronic immunosuppressed patient with rheumatoid arthritis.

Authors:  John A Batsis; Michael P Phy
Journal:  Clin Rheumatol       Date:  2005-04-23       Impact factor: 3.650

10.  Effect of serum heat-inactivation and dilution on detection of anti-WNV antibodies in mice by West Nile virus E-protein microsphere immunoassay.

Authors:  Madhuri Namekar; Mukesh Kumar; Maile O'Connell; Vivek R Nerurkar
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.